grant

Mechanistic insight into genome stability pathways

Organization UNIVERSITY OF VIRGINIALocation CHARLOTTESVILLE, UNITED STATESPosted 1 Jun 2021Deadline 31 May 2026
NIHUS FederalResearch GrantFY2025APF-1ATP-Dependent Proteolysis Factor 1AddressAffectAnimal AlternativesAnimal ModelAnimal Models and Related StudiesAnimal Testing AlternativesAutoregulationBasic Mechanisms of SUMOylationBody TissuesCancersCardiomyopathiesCell BodyCell CycleCell Division CycleCell LineCell modelCellLineCellsCellular modelChromosomesCoupledDNADNA HelicasesDNA ReplicationDNA SynthesisDNA Unwinding ProteinsDNA biosynthesisDNA mutationDNA replication forkDNA unwinding enzymeDefectDeoxyribonucleic AcidDevelopmentDiseaseDisorderDouble Strand Break RepairE3 LigaseE3 Ubiquitin LigaseEsteroproteasesFamilyGeneralized GrowthGeneticGenetic ChangeGenetic defectGenetic mutationGenomeGenome StabilityGenome engineeringGenomic StabilityGrowthHMG-20HeterozygoteHigh Mobility Protein 20HomeostasisHumanImmune systemIn VitroLaboratoriesLengthLesionLinkMaintenanceMalignant NeoplasmsMalignant TumorMitoticModelingModern ManMolecularMutationMyocardial DiseasesMyocardial DisorderMyocardiopathiesNetwork-basedNeurodevelopmental DisorderNeurological Development DisorderOrphan DiseasePathologyPathway interactionsPatientsPeptidasesPeptide HydrolasesPhasePhysiological HomeostasisPremature AgingPremature aging syndromeProtease GeneProteasesProteinasesProteinsProteolytic EnzymesRare DiseasesRare DisorderRing FingerRing Finger DomainRing Finger MotifRing-Type Zinc Finger DomainRoleSUMOylationSomatic CellStrains Cell LinesSumoylation PathwayTelomeraseTelomere MaintenanceTissue GrowthTissuesUbiquitilationUbiquitinUbiquitin Protein LigaseUbiquitin-Protein Ligase ComplexesUbiquitin-Protein Ligase E3UbiquitinationUbiquitinoylationWorkalternative to animalsalternatives to animals in researchcell typecellular developmentcultured cell linede-ubiquitinasede-ubiquitinating enzymedevelopmentaldisease causing variantdisease-causing alleledisease-causing mutationentire genomefull genomegenome editinggenome integritygenome mutationgenomic editinggenomic integrityhelicaseheterozygosityhuman diseasehypoimmunityiPSiPSCiPSCsimmune deficiencyimmunodeficiencyinduced pluripotent cellinduced pluripotent stem cellinducible pluripotent cellinducible pluripotent stem cellinsightinterestmalignancymodel of animalmyocardium diseasemyocardium disorderneoplasm/cancerneurodevelopmental diseasenew diagnosticsnew drug treatmentsnew drugsnew pharmacological therapeuticnew therapeuticsnew therapynext generation diagnosticsnext generation therapeuticsnovel diagnosticsnovel drug treatmentsnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel therapeuticsnovel therapyontogenyorphan disorderpathogenic allelepathogenic variantpathwayprogramsrepairrepairedreplace animal modelsreplace animal usereplacement for animal modelsreplacement for animal usereplication forkreplication stressresearch alternatives to animal usesocial roletelomereubiquinationubiquitin conjugationubiquitin isopeptidaseubiquitin-protein ligaseubiquitin-specific isopeptidasewhole genome
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Project Summary
Genome integrity depends on a robust DNA replication program and the activity of replication-coupled repair

pathways that operate during different phases of the cell cycle. My laboratory has had a longstanding interest in

the causes and consequences of replication stress. Replication stress arises when lesions in the genome persist

due to repair deficiencies or when components of the replication machinery are dysfunctional. Although disease-

causing mutations in essential replication factors are rare, they can cause pleiotropic and severe disorders, such

as immunodeficiency, cardiomyopathy, or growth defects. In recent years, we have investigated the molecular

mechanism that underlies these rare diseases. We have identified compound heterozygous patient mutations in

the replication factor minichromosome maintenance protein 10 (MCM10), and have modeled them in human

somatic cell lines. Although these mutations cause relatively mild cellular replication defects, they pose

significant problems to telomere maintenance. One caveat of the current cell models is that they are immortalized

and express telomerase constitutively. To better understand the impact of replication defects in the context of

cellular development of affected tissues, we propose to engineer genome-edited induced pluripotent stem cells

and differentiate them into specific cell types in vitro. This presents a valuable alternative to animal models which,

relevantly, do not fully mimic telomere homeostasis in humans. Moreover, we are interested in the pathways that

cells activate for survival under conditions of mild replication stress. Previous work has identified a network based

on ubiquitination and SUMOylation, and ring finger protein 4 (RNF4) as a key component. RNF4 is a SUMO-

targeted E3 ubiquitin ligase that has been implicated in double-strand break repair, however, its role at replication

forks and in telomere maintenance is not well understood. A genetic interaction screen has identified Bloom

helicase (BLM), a RecQ-family helicase that causes premature aging, and ubiquitin specific peptidase 7 (USP7),

a deubiquitinase, as strong negative interactors. Mutations in USP7 have been linked to rare

neurodevelopmental disorders, but its cellular action has remained obscure. Interestingly, USP7 and BLM also

regulate DNA replication and telomere length. We will investigate the relationship between RNF4, USP7 and

BLM in chromosome inheritance in telomerase-positive and -negative cells. Lastly, a common feature of

replication stress is under-replication due to an inability to duplicate the entire genome. As a result, single-

stranded gaps persist that can either be filled by post-replicative repair that is regulated by the ubiquitination of

PCNA or, as a last resort, by mitotic DNA synthesis (MiDAS). MiDAS is a break-induced replication (BIR)-like

pathway that, unlike a classical replication fork, copies DNA by displacement synthesis. We will study how

ubiquitinated PCNA controls MiDAS, and will determine whether other BIR-related pathways are regulated by

PCNA ubiquitination. In summary, the questions addressed in this proposal will elucidate fundamental and

disease-relevant mechanisms of genome stability pathways in human cells.

Grant Number: 5R35GM141805-06
NIH Institute/Center: NIH

Principal Investigator: Anja-Katrin Bielinsky

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Mechanistic insight into genome stability pathways — UNIVERSITY OF VIRGINIA | UNITED STATES | Jun 2021 | Dev Procure